Furthermore, it has been demonstrated that SOX2 is a target gene of miR-429 in gastric cancer cells and that miR-429 is connected to cisplatin resistance in cisplatin-resistant gastric cancer cells. This evidence concerns the gene SOX2 and gastric cancer.